“The President was not sleeping; in fact, he spoke extensively and answered numerous questions from the press during this announcement, which represents a historic reduction in prices for Americans on two essential drugs that help individuals struggling with diabetes, heart disease, obesity, and related conditions,” the statement read.
Details of the Medicare Announcement
The GLP-1 drugs covered in the briefing are designed to support individuals dealing with obesity, diabetes, and other metabolic conditions.
According to the administration, the policy changes would reduce costs for oral GLP-1 medications to $149 per month and injectable versions to $249 per month.
Advocates of the plan emphasized that these reductions could make the medications more accessible to millions of Americans struggling to afford essential treatments.
Dr. Oz, presenting the plan, remarked that these changes were intended to ease financial strain on patients while improving public health outcomes.
While Trump appeared to briefly slump in his seat, officials noted that he continued to interact with attendees and respond to questions from reporters throughout the event.
Despite the administration’s insistence, critics and commentators seized upon the moment to question whether the former president had the stamina to maintain attention and composure during extended or high-pressure public engagements.Continue reading…
